Boothbay Fund Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-56,784
| Closed | -$4.42M | – | 1327 |
|
2024
Q3 | $4.42M | Buy |
+56,784
| New | +$4.42M | 0.1% | 235 |
|
2024
Q2 | – | Sell |
-127,472
| Closed | -$8.64M | – | 1351 |
|
2024
Q1 | $8.64M | Buy |
127,472
+95,697
| +301% | +$6.48M | 0.17% | 76 |
|
2023
Q4 | $2.14M | Buy |
+31,775
| New | +$2.14M | 0.05% | 373 |
|
2023
Q3 | – | Sell |
-68,378
| Closed | -$4.89M | – | 1518 |
|
2023
Q2 | $4.89M | Buy |
68,378
+35,869
| +110% | +$2.57M | 0.11% | 172 |
|
2023
Q1 | $2.26M | Buy |
+32,509
| New | +$2.26M | 0.05% | 509 |
|
2022
Q4 | – | Sell |
-29,118
| Closed | -$1.6M | – | 1746 |
|
2022
Q3 | $1.6M | Buy |
+29,118
| New | +$1.6M | 0.04% | 577 |
|
2021
Q4 | – | Sell |
-65,155
| Closed | -$3.91M | – | 1686 |
|
2021
Q3 | $3.91M | Sell |
65,155
-61,890
| -49% | -$3.72M | 0.11% | 171 |
|
2021
Q2 | $7.61M | Sell |
127,045
-77,642
| -38% | -$4.65M | 0.24% | 62 |
|
2021
Q1 | $10.2M | Buy |
204,687
+105,617
| +107% | +$5.25M | 0.38% | 20 |
|
2020
Q4 | $4.95M | Buy |
99,070
+93,178
| +1,581% | +$4.66M | 0.18% | 73 |
|
2020
Q3 | $323K | Sell |
5,892
-15,330
| -72% | -$840K | 0.02% | 676 |
|
2020
Q2 | $1.12M | Sell |
21,222
-12,616
| -37% | -$667K | 0.08% | 290 |
|
2020
Q1 | $1.51M | Sell |
33,838
-39,070
| -54% | -$1.74M | 0.13% | 169 |
|
2019
Q4 | $3.64M | Sell |
72,908
-10,426
| -13% | -$520K | 0.32% | 56 |
|
2019
Q3 | $3.71M | Buy |
+83,334
| New | +$3.71M | 0.34% | 53 |
|
2017
Q3 | – | Hold |
0
| – | – | – | 523 |
|
2017
Q2 | – | Hold |
0
| – | – | – | 585 |
|